logo
8 Steps to the Perfect At-Home Facial

8 Steps to the Perfect At-Home Facial

Health Line19-05-2025

At-home facials may suit those who prefer the comfort of their own homes to relax and unwind while treating their skin. Learn what experts recommend including in your facial routine.
Treating yourself to a facial is one of life's little luxuries. But if you don't fancy a trip to the spa or prefer a cheaper alternative, an at-home facial could be the perfect option for you.
A multitude of skin care products and devices on the market make taking facial steps at home a walk in the park.
Nighttime is a great time to start. 'During the day, skin is in a more protective mode, but at night, skin is more relaxed and starting repair mode, so it can readily accept extra love,' says Renée Rouleau, celebrity aesthetician and founder of her eponymous skin care line.
Here's how you can treat yourself to a DIY facial.
Whether it's a tried-and-true skin care regimen, how often you wash your hair, or the cosmetics you're curious about, beauty is personal.
That's why we rely on a diverse group of writers, educators, and other experts to share their tips on everything from the way product application varies to the best sheet mask for your individual needs.
We only recommend something we genuinely love, so if you see a shop link to a specific product or brand, know that it's been thoroughly researched by our team.
Step 1: Cleanse
In order to maximize every step, the idea is to start with a clean slate. The general rule is that if you're wearing makeup, you should use a cleansing lotion or oil first. Then, you cleanse again with a lightly foaming gel or exfoliating cleanser to remove residue.
'The emollients used in makeup are removed more effectively with other emollients,' says Rouleau.
Start by massaging the lotion or oil on dry skin first. Then, wet your fingertips and massage it through a second time.
To rinse, Jennifer Swisher, aesthetician at SkinCeuticals SkinLab by Dr. Roth in Texas, recommends using a microfiber washcloth to provide lifting action and make sure it all comes off.
Next, cleanse again with a sulfate-free, low-foaming gel with nourishing components. These components won't dry your skin out.
'Your skin barrier is genetically coded to produce a certain amount of oil. If you fully strip that off, you're sending the wrong message to your skin to produce more oil, and that's when you create imbalances in your skin,' says Stevie McCord, esthetician and founder of Urban Alchemy Lab in Texas.
If you have oily skin, you may want to opt for a cleanser that helps remove excess oil.
For dry skin, you'll want something that cleans without stripping the skin.
And for normal skin, a cleanser that gently exfoliates while removing oil and dirt can be useful.
Step 2: Exfoliate
Exfoliating helps remove dead skin cells from the surface of your skin, and it helps make sure the rest of the products you apply are properly absorbed.
There are a few different types of exfoliators:
Physical exfoliators include products such as facial scrubs, at-home microdermabrasion tools, or derma-planing blades.
Chemical exfoliators refer to acids, like lactic or glycolic, which help dissolve dead skin cells.
For the ideal at-home facial, Rouleau recommends using both physical and chemical exfoliators, starting first with an acid exfoliator.
After leaving it on for 10 minutes or so, she recommends following it up with a physical scrub 'to make sure you actually remove the dead skin cells.'
You can also just do one or the other, depending on your skin type.
'Someone with oilier skin can get away with exfoliating four or five times per week,' says McCord. 'Someone with drier skin should exfoliate much less, about once a week.'
Step 3: Steam
Now that you're working with freshly exfoliated skin, you can steam with an at-home steamer.
Steaming offers several benefits.
'It heats up the internal temperature of the skin and slightly dilates the pores. This makes the hardened oils in the pores (aka blackheads) melt a little, making extractions easier to perform,' says Rouleau. 'It also increases blood flow to the skin, and it is very hydrating because it brings a lot of moisture to the skin.'
That said, if you steam, it's important to quickly follow up with moisturizing products, like a mask or an extraction (more on that below).
'You never want to leave skin bare after steaming because it will get tight and you will lose all that moisture,' adds Rouleau.
Steaming might not be suitable for those with skin problems, like melasma. If you're unsure whether steaming is the best step for your skin, consult a dermatologist.
If you're steaming at home, only do it for 5 to 10 minutes. Any longer than that and you risk dehydration.
Step 4: Extract
If you're considering extracting your own blackheads, it's important to do it correctly to prevent damage to your skin and pores.
Directions
If you're using an extractor tool, follow the manufacturer's instructions.
If using your fingers, wash your hands thoroughly.
Wrap your fingers in tissue or toilet paper.
Place your fingers around the comedo, and squeeze once.
Change your positioning to prevent marking up your skin or causing inflammation, and squeeze a second time.
If nothing comes out, move on.
Dab with a topical acne treatment.
Step 5: Mask
There are several kinds of masks, including:
Gel. Gel masks are cooling and calming to the skin and good for all skin types — especially those with redness and rosacea.
Clay. Clay masks are especially good for oily skin and clogged pores. The clay helps draw out impurities from the skin. 'If it dries and cracks into a million pieces, it means the mask is too strong,' says Rouleau. 'Look for a hydrating mask infused with ingredients that are nourishing for the skin.'
Cream. Cream masks usually have a heavy consistency. They're great for drier skin types that need more lipids, oils, and nourishing components.
Sheet masks. Sheet masks are typically gel, infused with water-based hydration. These masks are also great for dry skin types.
You can also DIY a great mask at home with ingredients like yogurt, honey, oatmeal, avocado, and papaya.
The perfect mask for you depends on your skin type. But no matter which type you reach for, leave it on for 10 to 20 minutes, then remove with a damp washcloth.
Step 6: Treat
Serums are great targeted treatments for specific skin concerns, like wrinkles and pigmentation. Serums contain active ingredients like niacinamide, antioxidants, peptides, vitamins A, C, and E, and even topical retinols.
For pigmentation issues, opt for a vitamin C serum.
For dry, red, or flaky skin, try a serum with peptides and niacinamide.
If you have wrinkles you'd like to target, retinols or phyto-retinols may be able to help.
Step 7: Moisturize
Following a serum, apply a good layer of your favorite moisturizer to lock it all in.
If your skin is oily, you can opt for a lightweight lotion. If your skin is dry, you might want to try a heavier cream for more moisture
Step 8: Massage
Including a little massage into your facial not only feels great, but it also helps to increase circulation and lymphatic drainage. This can result in a dewy, de-puffed complexion.
It may also reduce dullness and skin irritation, according to Swisher.
If you want to use your fingers, you can. But you may also want to use a roller and a nice facial oil for a final flourish (think of it as a topcoat for your moisturizer).
'Work from the middle out, and always go upward in motion,' says McCord. 'If you're going to work around the eyes, you need to make sure you have enough product around them. You certainly don't want to tug that area, since the tissue around the eyes is a lot thinner.'
If your skin is on the oilier side, you may be wary about using an oil on top of your moisturizer, but McCord recommends it 'because it actually helps to balance out [your] sebum production.'
For oily skin, McCord recommends jojoba or sesame oil, while coconut, borage, rosehip, or avocado oil are great options for those with dry skin. If your skin is a little in between? You can never go wrong with frankincense or marula oil.
Last but not least, dab on a little eye cream around the eyes.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ask the Expert: Should I have Biomarker Testing – and Would it Help?
Ask the Expert: Should I have Biomarker Testing – and Would it Help?

Health Line

time35 minutes ago

  • Health Line

Ask the Expert: Should I have Biomarker Testing – and Would it Help?

Biomarker testing in colorectal cancer can help assess inherited risk and identify characteristics that may influence the disease's growth, spread, and response to treatment. Colorectal cancer (CRC) starts in the colon or rectum of the large intestine. Your doctor may refer to it as 'colon cancer' or 'rectal cancer,' depending on where the cancer develops first, but both of these diagnoses are included under the banner of CRC. CRC is treatable, and biomarker testing is a part of precision medicine in your comprehensive treatment plan. Biomarker testing in CRC can help detect cancer in its earliest, most treatable stages. It can also provide important details about cancer after a diagnosis that influence treatment and outcomes. Dr. Smitha Krishnamurthi, a gastrointestinal oncology specialist with the Cleveland Clinic, talks with Healthline about biomarker testing and who it's recommended for. What is biomarker testing? Biomarker testing refers to testing of the colorectal cancer to find out if there are certain changes in the cancer's genes and proteins that could impact prognosis [outlook] and treatment. What are the most common biomarkers, and what do they show? Biomarkers in CRC measure a variety of different biological processes and states. Each biomarker provides important details about the cancer's growth, spread, or treatment response. DNA mismatch repair Hospital pathology labs now commonly test all initial biopsies or surgical specimens of colorectal cancer for the presence of DNA mismatch repair proteins. This is done via immunohistochemistry (IHC) staining of the slides to look for [the] expression of four mismatch repair proteins: MLH1, PMS2, MSH2, and MSH6. If one or two of these proteins are missing, then the cancer has deficient DNA mismatch repair. Microsatellite instability (MSI) This is a polymerase chain reaction (PCR) or next-generation sequencing (NGS) test [that looks] for abnormalities in microsatellite regions of the cancer DNA. The test can be done on a tumor specimen or blood (liquid biopsy). Microsatellites are short, repeated sequences of DNA. If the cancer has [atypical] DNA mismatch repair, errors will appear in microsatellite regions of DNA in the form of missing bases or extra bases added to the DNA sequence. RAS gene mutations (mutations in KRAS and NRAS genes) This testing can be performed by PCR or NGS testing of the tumor or NGS testing of blood (liquid biopsy). RAS is a very important oncogene, meaning that it is a gene that, when mutated, drives cancer cell proliferation and survival. Mutations in RAS genes are found in up to 50% of colorectal cancers. BRAF V600E gene mutation This testing can be performed by PCR or NGS testing of the tumor or NGS testing of blood (liquid biopsy). The BRAF V600E protein can also be detected by IHC. BRAF is another oncogene, so when it is mutated, it leads to cancer cell proliferation and survival. BRAF V600E mutations occur in about 8% to 10% of colorectal cancers and are more common in right-sided cancers. HER2 protein overexpression by IHC or gene amplification by NGS HER2 is another oncogene — gene amplification leads to [the] overexpression of the HER2 protein. Overexpression of HER2 leads to increased signaling via the epidermal growth factor receptor pathway, leading to cancer cell proliferation and survival. PIK3CA PIK3CA is another oncogene. Mutations in PIK3CA and a related gene, PIK3R1, lead to cancer cell proliferation and survival. Mutations in PIK3CA and PIK3R1 are typically found via NGS. PTEN PTEN is a tumor suppressor gene, [which typically] suppresses cancer growth. When the PTEN gene is mutated, the protein is not expressed, and that leads to [the] proliferation of cancer. PTEN gene mutations are typically found via NGS. Who should have biomarker testing done? All patients with colorectal cancer should have testing of their cancer for DNA mismatch repair (or microsatellite instability) soon after diagnosis. This is important for patients with cancers of all stages. Patients with early stage colorectal cancer should have testing of their cancers for mutations in PIK3CA, PTEN, and PIK3R1 by the time they finish adjuvant treatment or after surgery if [they're] not having adjuvant treatment. Patients with metastatic colorectal cancer should have next-generation sequencing of the cancer soon after diagnosis, as the results may impact the initial systemic treatment. The NGS results are also useful for identifying clinical trial eligibility. Comorbidities will not affect the results of these biomarkers, so they should not affect the timing and decision making about ordering these tests. How does biomarker testing help the treatment and outcome of a diagnosis? Biomarkers can impact your treatment choices and outcomes. They can help doctors decide which medications will be the most effective, identify inherited features in cancer, and determine if adjuvant or additional therapies would improve outcomes. Immunotherapy responsiveness It is critical to know if a cancer has deficient DNA mismatch repair (dMMR) or high microsatellite instability (MSI-H) because these cancers can respond dramatically to immunotherapy in the early stage and metastatic settings. For example, patients with rectal cancer that is dMMR or MSI-H may have a complete clinical response with immunotherapy and may be able to avoid radiation and surgery. Thus, this testing needs to be done early, before treatment starts. Identifying Lynch syndrome Another important reason for testing for dMMR or MSI-H is to identify cancers caused by Lynch syndrome. Lynch syndrome is the most common type of inherited colorectal cancer and is caused by germline mutations in the genes that code for the DNA mismatch repair proteins or in another related gene called EPCAM. Most cancers with deficient mismatch repair or MSI-H are not caused by Lynch syndrome and occur sporadically. We don't want to miss patients with Lynch syndrome, however, because they can benefit from counseling about [the] prevention of Lynch syndrome-related cancers such as uterine cancer, ovarian cancer, and gastric cancer, in addition to colorectal cancer. When a patient is diagnosed with Lynch syndrome, family members can then be tested to see if they have Lynch syndrome. Recommendations for cancer screening at early stages are made for individuals with Lynch syndrome, and early screening can be lifesaving. Identifying treatment resistance Mutations in KRAS and NRAS make cancers resistant to anti-epidermal growth factor receptor therapy. Cancers with KRAS G12C mutations can be treated with a regimen that targets this mutation (adagrasib plus cetuximab or sotorasib plus panitumumab). There are also many clinical trials now studying RAS gene inhibitors in patients with metastatic colorectal cancer that have been previously treated. Cancers with BRAF V600E tend to be aggressive and less sensitive to chemotherapy. There is a Food and Drug Administration (FDA)-approved regimen targeting BRAF V600E (encorafenib plus cetuximab) in metastatic colorectal cancer that improves survival when added to first-line FOLFOX chemotherapy. It also improves survival as a second-line treatment after chemotherapy. Greater response to targeted and adjuvant therapy Metastatic colorectal cancers that demonstrate [the] overexpression or gene amplification of HER2 can be treated with a targeted regimen of tucatinib plus trastuzumab after initial chemotherapy. Another targeted treatment available for metastatic colorectal cancers that overexpress HER2 by IHC is trastuzumab deruxtecan. Patients with early stage colorectal cancer with mutations in the PIK3CA, PIK3R1, or PTEN genes should be treated with aspirin 160 milligrams daily for 3 years after adjuvant therapy or after surgery if [they're] not having adjuvant therapy. The ALASCCA trial, presented at ASCO GI [American Society of Clinical Oncology – Gastrointestinal Cancer] in 2025, compared a placebo to aspirin in this patient population and found that aspirin significantly lowered the rate of cancer recurrence at 3 years. This is rather new data. Oncologists are starting to order NGS testing for patients with early stage cancers in order to obtain this biomarker information. What should you ask your doctor? It's always OK to ask your doctor about biomarker testing and what it means for you. Important questions to consider include: Is my cancer dMMR/MSI-H? Am I a candidate for immunotherapy? Patients with early stage colorectal cancer should ask if aspirin therapy will be recommended based on biomarker testing. Patients with metastatic colorectal cancer should ask for the results of RAS/BRAF/HER2 testing and overall NGS testing results.

Palantir and TeleTracking Team Up to Enhance Healthcare Operations Using AI-Driven Insights
Palantir and TeleTracking Team Up to Enhance Healthcare Operations Using AI-Driven Insights

Yahoo

time39 minutes ago

  • Yahoo

Palantir and TeleTracking Team Up to Enhance Healthcare Operations Using AI-Driven Insights

TeleTracking Technologies, a leading provider of healthcare operations platforms, has teamed up with Palantir Technologies Inc. (NASDAQ:PLTR), known for its expertise in artificial intelligence systems. The two companies have formed a strategic partnership with the goal of transforming how hospitals and health systems make operational decisions, ultimately creating long-term value for healthcare providers around the world. The collaboration will integrate TeleTracking's Operations IQ platform with Palantir Technologies Inc. (NASDAQ:PLTR)'s AI-driven tools, including Foundry and AIP. This combined solution is expected to equip hospitals with near real-time, actionable insights to improve staffing efficiency, speed up decision-making, and ensure that patient needs remain the top priority. As healthcare systems continue to face increasing demands to enhance capacity and coordination without expanding their physical footprint, this partnership represents a significant step forward. By bringing together TeleTracking's operational strengths and Palantir Technologies Inc. (NASDAQ:PLTR)'s cutting-edge technology, the two aim to usher in a new era of intelligent, scalable, and efficient healthcare delivery. Alex Karp, CEO at Palantir Technologies Inc. (NASDAQ:PLTR) made the following comment: 'This partnership with TeleTracking represents the AI revolution in healthcare we are in the midst of—where we continue to move closer to a world where all hospitals and health systems are embracing, implementing and operating with an AI-powered approach, helping to streamline operations allowing for increased focus on providing the best level of care.' Palantir Technologies Inc. (NASDAQ:PLTR) is an American publicly traded company that focuses on developing software platforms designed for analyzing large volumes of data. While we acknowledge the potential of PLTR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

New Iowa law expands cancer coverage for firefighters
New Iowa law expands cancer coverage for firefighters

Yahoo

timean hour ago

  • Yahoo

New Iowa law expands cancer coverage for firefighters

A bill intended to expand cancer coverage for firefighters in Iowa is now law. Gov. Kim Reynolds signed House File 969. The bill expands the definition of cancer to include all types of cancer. Currently, only 14 cancers are currently included in coverage for firefighters, police officers and emergency responders. First responders with one of those types cancers are able to qualify for disability and death benefits. Before the passage of the bill, those with other types of cancers were not. Iowa firefighters Brian Stoaks, Mike Broderick and Malcolm Cortner all passed away from cancer. Their families and friends continued the fight until the bill passed. The bill was shot down last year. For more information, click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store